Navigation Links
New research to reduce drug side-effects
Date:7/10/2009

They are a group of drugs which millions of people rely on to keep pain at bay but they can have unwanted side-effects which are sometimes more serious than the original health problem. Now scientists at The University of Nottingham are taking part in the largest-ever study on the safety of Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) that has ever been performed.

The project is called SOS (Safety Of non-Steroidal anti-inflammatory drugs) and will study the medical information of 35 million people in Europe to assess the incidence and nature of harmful side-effects on the cardiovascular and gastrointestinal systems of patients. It's hoped the results will lead to better guidance for doctors on how to balance the advantages of prescribing the drugs with the associated risks of heart and digestive problems.

NSAIDS are widely used in medicine for treating pain, inflammation and degenerative diseases like arthritis. The most commonly-used are aspirin and ibuprofen. But their use is associated with an increased risk of minor and serious gastrointestinal complications. It's estimated that there are thousands of these cases in the European Union every year. Prompted by these problems, a new class of NSAIDS called 'Coxibs' have been developed to reduce the risk of this type of side-effect, but the use of these new drugs has since been linked with an increased risk of heart problems such as heart attack and stroke.

Clinicians and scientists now agree that the risk of stomach problems has to be balanced against the risk of cardiovascular interference. Both risks may differ in one person and for the 30 different types of NSAIDS available in the EU. Up to now research studies have been too small to be effective in terms of providing decision models for doctors and drug regulators but it's hoped this new large survey will result in a much more accurate prescription method to minimize drug-related harm.

Over the next two and a half yea
'/>"/>

Contact: Professor Julia Hippisley-Cox
julia.h-cox@nottingham.ac.uk
44-011-584-66915
University of Nottingham
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pre-cessation patch doubles quit success rate: Researchers call for labeling changes
2. Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011
3. Velos, Inc. Launches Velos On-Demand for Velos eResearch, Bringing Dynamically Scalable Economy to Customers
4. 'Comparative Effectiveness' Research Addresses Options for Treating Prostate Cancer
5. Lupus Foundation of America Accepting Letters of Intent for Research Grants on Adult Stem Cell Research and Health-Related Quality of Life in Pediatric Lupus
6. Researchers identify potential patient safety risks among methadone maintenance treatment patients
7. Photos: $8 Million in Asthma Research Grants Awarded to 12 Scientists
8. Kessler Foundation Research Center Awarded More Than Two Million Dollars in Grants
9. Cardinal Rigali Criticizes Final NIH Guidelines for Destructive Stem Cell Research
10. DOE funds Clemson University clean energy research
11. UT Southwestern researcher named HHMI Early Career Physician-Scientist
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Oceanside,CA (PRWEB) January 22, 2015 For over 20 ... the Oceanside and Vista area has treated just about ... other personal injury circumstances. And for those same twenty-plus years, ... victims of all those injuries with the best possible doctor. ...
(Date:1/22/2015)... Yesterday, Senator Holly Mitchell (D-Los ... Olsen (R-Modesto) were honored by the California Healthcare ... biomedical science, medical device and pharmaceutical innovation in ... “2014 Life Sciences Champion” award from CHI President ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... January 22, 2015 Compare-autoinsurance.org has released a new ... by an auto insurance policy . , Some types ... Clients should check the newly released blog post to see if ... and dangerously damaged vehicles are some of the cars that cannot ...
(Date:12/26/2014)... The US represents the largest market for CRC ... forecast estimates that sales of branded therapies were $2.23 billion. ... high incidence of the disease, high drug treatment rate, and ... Increased sales of CRC therapies over the forecast period will ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 2Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 3Health News:US Colorectal Cancer Drug Market Analysis and Forecast to 2023 Report Available at ReportsnReports.com 4
... Challenge on First Day ... Illnesses, MINNEAPOLIS, June 5 Just one more hour ... mortality causing,illnesses including obesity, Type 2 diabetes, respiratory disorders and,high ... activities into your day, the sleep experts at Select Comfort(R),(Nasdaq: ...
... Indicator of Failures to Provide Basic Health Care,to Women, ... White,Ribbon Alliance for Safe Motherhood today made public its ... on Africa to invest in,women,s health as necessary to ... childbirth. "While we, too, see tremendous opportunity in,this, the ...
... SAN CARLOS, Calif., June 5 Nuvelo, Inc.,(Nasdaq: ... preclinical data from the,company,s Wnt Therapeutics program showing ... pathway, a signaling pathway that is critical for,cell ... proteins also amplified the activity of Wnt proteins, ...
... Charterhouse Group, Inc.,("Charterhouse") a New York-based ... supported growing middle-market companies since 1973,announced today ... and MTS Health Investors ("MTS") to complete ... ("CEA" or the "Company"), the,market leader in ...
... for Right To ... Red Ball Child Play Program, MORRIS PLAINS, N.J., June 5 ... makers of LISTERINE(R)* to help,Americans bring the benefits of healthy sports ... healthy routines,and physical activity, LISTERINE(R)* and the Hamm brothers are supporting,the ...
... Ticker Symbol: CUR, QUEBEC CITY, June 5 ... company commercializing high-value cancer diagnostic,tests and delivering laboratory ... second quarter 2008 financial results on June 13, ... be followed by a conference,call, which will be ...
Cached Medicine News:Health News:Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on 'Longest' Day of the Year 2Health News:Summer is for Sleeping? Exhausted Americans Challenged to Sleep-in on 'Longest' Day of the Year 3Health News:White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Women's Health 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 2Health News:Nuvelo Announces Publication of Preclinical Data From Wnt Therapeutics Program 3Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 2Health News:Charterhouse Group Partners with MTS Health Investors and Highlander Partners to Acquire Chamberlin Edmonds & Associates, Inc., a Leading Provider of Eligibility Services to Hospitals 3Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 2Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 3Health News:Olympic Medalists Paul and Morgan Hamm Challenge Americans to Help Children-in-Need Worldwide 4Health News:DiagnoCure to host Q2 2008 earnings conference call and webcast 2
(Date:1/23/2015)... N.J. , Jan. 23, 2015  CytoSorbents Corporation ... commercializing its CytoSorb® extracorporeal cytokine adsorber to reduce ... announced the receipt of $385,642, net of transaction ... of the Technology Business Tax Certificate Transfer Program ...
(Date:1/23/2015)... Jan. 23, 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... in the development and sale of patented biopharmaceutical medicine, ... pharmaceutical ingredients (API) today announced the business and development ... 1. Following the September 2014 JCM application ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 2CytoSorbents Receives $385,000 in Non-Dilutive Funding from the New Jersey Technology Business Tax Certificate Transfer Program 3TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... ... ... ... ...
... ... ... ... ...
Cached Medicine Technology:Watson Signs Agreement to Divest Equity Interest in ScinoPharm 2Watson Signs Agreement to Divest Equity Interest in ScinoPharm 3Watson Signs Agreement to Divest Equity Interest in ScinoPharm 4Watson Signs Agreement to Divest Equity Interest in ScinoPharm 5HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 2HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 3HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 4HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 5HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 6HIMSS Honors Memorial Healthcare System for Using TheraDoc(TM) Decision Support Technology to Achieve 97 Percent Compliance With Pediatric Asthma Quality Measures 7
Mini blades....
... OH3 is a smart system ... available on the market with ... The Leica M520 OH3 is ... range of movement and is ...
Operating microscope with motorized zoom and variable focus up to 405 mm....
Advanced operating microscope with high-resolution apochromatic optics. Senso-servo drive to keep the microscope in perfect balance even if parts are moved or mounted elsewhere....
Medicine Products: